Skip to content

Determination of 50% and 95% effective doses of Oliceridine for inhibiting the uterine contraction pain after painless artificial abortion by sequential test methods

Determination of 50% and 95% effective doses of Oliceridine for inhibiting the uterine contraction pain after painless artificial abortion by sequential test method

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400091831
Enrollment
Unknown
Registered
2024-11-05
Start date
2024-11-05
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

NONE

Interventions

experimental group:Osalidine

Sponsors

Weifang People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: Select patients who undergo elective painless artificial abortion surgery in early pregnancy (<14 weeks), aged 18-35 years, with a BMI of 18.0-28.0 kg/m2 and ASA grade I or II.

Exclusion criteria

Exclusion criteria: Allergies to oxaliplatin and cyclosporine; Suspected or confirmed history of long-term use of anesthetics and sedatives; History of sleep apnea syndrome; Identify difficult airways; Those who have mental or neurological disorders that affect cognitive function and have poor cooperation with physicians. After the surgery, if there is poor uterine contractions, additional use of oxytocin is required; Postoperative emotional fluctuations and misunderstanding of VAS pain score; Poor cervical conditions, difficult dilation procedures, and even cervical tears.

Design outcomes

Primary

MeasureTime frame
the uterine contraction pain after painless artificial abortion; the uterine contraction pain after painless artificial abortion;the uterine contraction pain after painless artificial abortion;

Secondary

MeasureTime frame
hypoxemia;bradycardia;

Countries

China

Contacts

Public ContactRuYan

Weifang People's Hospital

670416973@qq.com+86 183 5368 8150

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026